FDA Guidance for Industry: Pharmaceutical Components at Risk for Melamine Contamination

Titel:
FDA Guidance for Industry: Pharmaceutical Components at Risk for Melamine Contamination
Herkunft/Verlag:

FDA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM175984.pdf

Inhalt:
Hilfestellung zum Risiko der Melaninkontamintion

Zurück

GMP Seminare nach Thema